Revenue Insights: Halozyme Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Performance Compared

Biotech Revenue Growth: Halozyme vs. Ligand

__timestamp	Halozyme Therapeutics, Inc.	Ligand Pharmaceuticals Incorporated
Wednesday, January 1, 2014	75334000	64538000
Thursday, January 1, 2015	135057000	71914000
Friday, January 1, 2016	146691000	108973000
Sunday, January 1, 2017	316613000	141102000
Monday, January 1, 2018	151862000	251453000
Tuesday, January 1, 2019	195992000	120282000
Wednesday, January 1, 2020	267594000	186419000
Friday, January 1, 2021	443310000	277133000
Saturday, January 1, 2022	660116000	196245000
Sunday, January 1, 2023	829253000	131314000
Monday, January 1, 2024	1015324000

In pursuit of knowledge

Revenue Growth: A Tale of Two Biotech Companies

In the competitive landscape of biotechnology, Halozyme Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated have showcased distinct revenue trajectories over the past decade. From 2014 to 2023, Halozyme's revenue surged by over 1,000%, reflecting its strategic advancements and market adaptability. In contrast, Ligand Pharmaceuticals experienced a more modest growth of approximately 100% during the same period.

Key Insights

Halozyme Therapeutics: Starting with a revenue of $75 million in 2014, Halozyme's revenue reached an impressive $829 million by 2023. This growth underscores its successful product pipeline and strategic partnerships.
Ligand Pharmaceuticals: Despite a slower growth rate, Ligand's revenue peaked in 2018 at $251 million, before stabilizing around $131 million in 2023.

These trends highlight the dynamic nature of the biotech industry, where innovation and strategic foresight are key to sustained growth.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025

Similar Statistics

Novartis AG vs Halozyme Therapeutics, Inc.: Annual Revenue Growth Compared

Amgen Inc. or Halozyme Therapeutics, Inc.: Who Leads in Yearly Revenue?

Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.: Annual Revenue Growth Compared

Comparing Revenue Performance: Zoetis Inc. or Halozyme Therapeutics, Inc.?

Regeneron Pharmaceuticals, Inc. and Halozyme Therapeutics, Inc.: A Comprehensive Revenue Analysis

Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis

Who Generates More Revenue? Catalent, Inc. or Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis

Revenue Showdown: Halozyme Therapeutics, Inc. vs Geron Corporation

Who Generates More Revenue? Cytokinetics, Incorporated or Ligand Pharmaceuticals Incorporated

Revenue Insights: Alkermes plc and Ligand Pharmaceuticals Incorporated Performance Compared

Annual Revenue Comparison: Ligand Pharmaceuticals Incorporated vs Evotec SE